UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 1-31719 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Iden ...

Molina Healthcare, Inc. (NYSE:MOH) Q4 2021 Earnings Conference Call February 10, 2022 8:00 AM ET Company Participants Joe Krocheski - Senior Vice President- Investor Relations Joe Zubretsky - President & Chief Executive Officer Mark Keim - Chief Financial Officer Conference Call Participants Kevin Fischbeck - Bank of America Arianna Brady - BMO Capital Markets Nathan Rich - Goldman Sachs Stephen Baxter - Wells Fargo Michael Hall - Morgan Stanley Josh Raskin - Nephron Research Justin Lake - Wolfe Research AJ ...

Molina Healthcare, Inc. (NYSE:MOH) Q3 2021 Earnings Conference Call October 28, 2021 8:00 AM ET Company Participants Joe Krocheski - Senior Vice President- Investor Relations Joe Zubretsky - President & Chief Executive Officer Mark Keim - Chief Financial Officer Conference Call Participants Matt Borsch - BMO Capital Markets Josh Raskin - Nephron Research Stephen Baxter - Wells Fargo Michael Hall - Morgan Stanley Justin Lake - Wolfe Research Steven Valiquette - Barclays A.J. Rice - Credit Suisse Kevin Fischb ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission file number: 001-31719 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) (S ...

Molina Healthcare, Inc. (NYSE:MOH) Q2 2021 Earnings Conference Call July 29, 2021 8:00 AM ET Company Participants Julie Trudell - Senior Vice President, Investor Relations Joe Zubretsky - President & Chief Executive Officer Mark Keim - Chief Financial Officer Conference Call Participants Kevin Fischbeck - Bank of America Matt Borsch - BMO Capital Markets A.J. Rice - Cr??dit Suisse Steven Valiquette - Barclays Justin Lake - Wolfe Research Dave Windley - Jefferies Scott Fidel - Stephens Josh Raskin - Nephron ...

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission file number: 001-31719 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) (State ...

Molina Healthcare, Inc. (NYSE:MOH) Q1 2021 Earnings Conference Call April 29, 2021 8:00 AM ET Company Participants Julie Trudell - SVP, IR Joseph Zubretsky - President and CEO Mark Keim - CFO Conference Call Participants Kevin Fischbeck - Bank of America A.J. Rice - Credit Suisse Scott Fidel - Stephens Justin Lake - Wolfe Research Ricky Goldwasser - Morgan Stanley Steve Valiquette - Barclays Joshua Raskin - Nephron Research Matthew Borsch - BMO Capital Markets Operator Good morning and welcome to the Molina ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission file number: 001-31719 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) (State ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 1-31719 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Iden ...

| --- | --- | |----------------------------------------------------------------------------------------------------------------------------------------|-------| | | | | | | | | | | 4Q20 Earnings | | | | | | Supplement | | | | | | February 10, 2021 | | | This 4Q20 Earnings Supplement should be read together and in conjunction with the Company's earnings release dated February 10, 2021. | | Cautionary Statement Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995 This presentation ...